NCT01871493View on ClinicalTrials.gov

A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

LY2605541

Administered subcutaneous (SQ)

DRUG

Insulin Lispro

Administered SQ

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01871493 - A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants | Biotech Hunter | Biotech Hunter